Aktinos Pharma Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2007.
2007 Hyderabad, Telangana, India Amalgamated
Last Updated:
Access Report
About Aktinos Pharma Private Limited

Aktinos Pharma Private Limited, a amalgamated private limited company, was established on 13 September 2007 in Hyderabad, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24232TG2007PTC055510. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹20.00 Cr and a paid-up capital of ₹4.03 Cr.

It upholds a compliant status. Employing 411 professional, Its leadership includes Murali Krishna Madala (Managing Director), Vineeth Madala (Director), Ravishanker Kovi (Director). Past directors included Murali Krishna Madala, Madhavi Thirividhi, Vineeth Madala. It holds ₹104.88 Cr open charges and ₹50.36 Cr settled loans. Its latest AGM occurred on 30 December 2024, with the balance sheet filed on 31 March 2024. It is based at Sri Lakshmi Spaces, 5Th Floor, Plot No. 7, Block No. B, Kavuri Hills, Phase- I, Mad, Hapur, Hyderabad, Telangana, 500033.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232TG2007PTC055510

  • Registration Number

    055510

  • Incorporation Date

    13 September 2007

  • Authorized Capital

    ₹20.00 Cr

  • Paid-Up Capital

    ₹4.03 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Amalgamated

Key Metrics
  • Authorised Capital ₹ 20.00 Cr
  • Paid Up Capital ₹ 4.03 Cr
  • Company Age 18 Year, 6 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 104.88 Cr
  • Satisfied Charges ₹ 50.36 Cr
  • Revenue Growth **** 8873335.30%
  • Profit Growth **** -203180804.24%
  • Ebitda **** 265586.29%
  • Net Worth 7260873.09%
  • Total Assets **** 10906056.62%
Company report

Aktinos Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Aktinos Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Aktinos Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Murali Krishna Madala Managing Director 13 Sep 2007 Current
Vineeth Madala Director 01 Aug 2022 Current
Ravishanker Kovi Director 24 Jul 2017 Current
Srilakshmi Madala Whole-Time Director 13 Sep 2007 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Nov 2007 Past
Pramod Abcsdd Director 30 Sep 2013 Past
Pramod Abcsdd Whole-Time Director 31 Aug 2023 Past
Pramod Abcsdd Whole-Time Director 28 Nov 2015 Past
Pramod Abcsdd Director 01 Oct 2009 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Aktinos Pharma.

Aktinos Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 8873335.3% increase. The company also saw a substantial fall in profitability, with a 203180804.24% decrease in profit. The company's net worth Soared by an impressive increase of 7260873.09%.

Aktinos Pharma revenue growth over time
Aktinos Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 8873335.30%
*******
*******
*******
*******
Revenue from Operations
*******
 8866757.35%
*******
*******
*******
*******
Total Assets
*******
 10906056.62%
*******
*******
*******
*******
Profit or Loss
*******
 -203180804.24%
*******
*******
*******
*******
Net Worth
*******
 7260873.09%
*******
*******
*******
*******
EBITDA
*******
 265586.29%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Aktinos Pharma?

In 2023, Aktinos Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹1,048,765,785.00

Satisfied Charges

₹503,642,196.00

Charges Breakdown by Lending Institutions
  • Others : 34.04 Cr
  • Axis Bank Limited : 16.32 Cr
Latest Charge Details
Date Lender Amount Status
28 Feb 2023 Others ₹1.71 Cr Satisfied
28 Feb 2022 Others ₹1.38 Cr Satisfied
22 Apr 2021 Others ₹5.00 Cr Satisfied
03 Apr 2017 Axis Bank Limited ₹16.32 Cr Satisfied
02 Jul 2012 Others ₹17.75 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Aktinos Pharma?

Aktinos Pharma has a workforce of 411 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Aktinos Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aktinos Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Aktinos Pharma
Recent Activity within the Organization
  • Charges

    Progress on A charge registered on 28 Feb 2023 via Charge ID 100695749 with Others was fully satisfied on 19 Mar 2025. was documented.

  • Charges

    The activity A charge registered on 28 Feb 2022 via Charge ID 100559027 with Others was fully satisfied on 19 Mar 2025. was completed.

  • Charges

    Progress on A charge registered on 22 Apr 2021 via Charge ID 100443999 with Others was fully satisfied on 30 Jan 2025. was documented.

  • Annual General Meeting

    Progress on Aktinos Pharma Private Limited last Annual general meeting of members was held on 30 Dec 2024 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Aktinos Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.

  • Charges

    The activity A charge registered on 03 Apr 2017 via Charge ID 100094654 with Axis Bank Limited was fully satisfied on 01 Mar 2023. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Aktinos Pharma Private Limited?

The CIN of Aktinos Pharma Private Limited is U24232TG2007PTC055510.

Where is Aktinos Pharma Private Limited headquartered?

Aktinos Pharma Private Limited is headquartered at Sri Lakshmi Spaces, 5Th Floor, Plot No. 7, Block No. B, Kavuri Hills, Phase- I, Mad, Hapur, Hyderabad, Telangana, 500033.

When was Aktinos Pharma Private Limited incorporated?

Aktinos Pharma Private Limited was incorporated on 13 September 2007.

Who are the current directors of Aktinos Pharma Private Limited?

The current directors of Aktinos Pharma Private Limited are

What is the primary industry of Aktinos Pharma Private Limited?

The primary industry of Aktinos Pharma Private Limited is Manufacturing.

Is Aktinos Pharma Private Limited a listed company?

Aktinos Pharma Private Limited is unlisted.

What is the capital structure of Aktinos Pharma Private Limited?

The authorized capital of Aktinos Pharma Private Limited is ₹20.00 Cr, and the paid-up capital is ₹4.03 Cr.

What is the compliance status of Aktinos Pharma Private Limited?

The compliance status of Aktinos Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available